Blood News and Research

RSS

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.

19 Mar 2011

Oncologists to discuss treatment of blood cancer in elderly

Top oncologists are meeting in Rome today to discuss the treatment of blood cancer in the elderly, with the aim of driving widespread change to ensure equality of care for everyone, whatever their chronological age.

19 Mar 2011

Researchers identify protein that triggers immune response in TB-infected people

Scientists have discovered a protein secreted by tuberculosis bacteria that could be a promising new vaccine candidate, they report today in Proceedings of the National Academy of Sciences. The protein could also be used to improve diagnosis of TB.

19 Mar 2011

Researchers discover process that regulates DNA maintenance

DNA contains all of the genetic instructions that make us who we are, and maintaining the integrity of our DNA over the course of a lifetime is a critical, yet complex part of the aging process.

19 Mar 2011

Experts to present latest information on multiple myeloma at Patient Symposium

The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.

18 Mar 2011

JHUSON adds Harvey the Cardiopulmonary Simulator to simulation education

It's official: Harvey the Cardiopulmonary Simulator checked in for an extended stay at the Johns Hopkins University School of Nursing (JHUSON) last month. Harvey is the latest addition to the School's upgraded simulation laboratories and the newest member of the "Sim Fam." These life-like practice manikins, including Sim Man, Vital Sim Man,Noelle with newborn, and Sim Baby give nursing students the hands-on experience without the anxiety of working with actual human beings.

18 Mar 2011

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Major clinical studies that evaluate prevention strategies for heart disease and stroke fail to consider a participant's ethnicity, a factor that can more than double the rate of death in some groups, according to research led by St. Michael's Dr. Joel Ray.

18 Mar 2011

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.

18 Mar 2011

UCLA researchers identify new biomarker that can help track amyloid beta in Alzheimer's

UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.

18 Mar 2011

Stem cell therapy can reduce heart size, scar tissue and improve function in cardiac patients

Researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas, according to a small trial published in Circulation Research: Journal of the American Heart Association.

18 Mar 2011

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

An international consortium led by scientists from the Cancer Research UK London Research Institute, The Royal Marsden Hospital and the Technical University of Denmark has been granted nearly £5million by the European Union to identify gene targets for personalised treatment for kidney cancer patients.

18 Mar 2011

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.

From Quest Diagnostics 18 Mar 2011

BUSM scientists identify new biomarker and melanoma treatment target

Researchers at Boston University School of Medicine, in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma.

18 Mar 2011

Stem cell therapy successfully heals a scarred and failing heart

A new study has shown that stem cells could heal scars caused by old heart attacks. In all eight patients who received the experimental treatment in an ongoing clinical trial this therapy worked. All of them had suffered heart attacks an average of 5 1/2 years prior; one of the patients had his heart attack 11 years earlier.

17 Mar 2011

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

Sports medicine physician Steve Watts says cardiac screening for young athletes is useful in preventing sudden cardiac death and suggests new diagnostics have the potential to add value and change the debate about the viability of cardiac screening for young athletes in the United States.

17 Mar 2011

FDA grants CSI marketing clearance for Stealth 360° Orbital PAD System

Cardiovascular Systems, Inc. has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA), and has begun a limited market release for the Stealth 360°™ Orbital PAD System. The Stealth 360° propels CSI into the forefront of treating peripheral arterial disease (PAD) with a simpler design that gives physicians complete control of device operation.

17 Mar 2011

APS ACTION brings experts together to improve patient outcomes

Motivated by the lack of treatment options for patients with antiphospholipid syndrome, rheumatology researchers convened an international committee to address the problem directly.

17 Mar 2011

Kentucky Governor signs license bill to practice diabetes education

Kentucky Governor Steve Beshear signed a bill yesterday that requires a license to practice diabetes education, a move that the American Association of Diabetes Educators says will enhance consumer protection and increase professional recognition.

17 Mar 2011

Major breakthrough in thrombosis

Scientists from the University of Reading have announced a major breakthrough in understanding how to control blood clotting which could lead to the development of new treatments and save the lives of thousands of people each year.

17 Mar 2011

Highmark forces patients with PIDD to switch over to specific IgG therapy

Beginning April 1, Highmark Blue Cross Blue Shield will force their insured patients with primary immunodeficiency diseases and other rare disorders to switch their prescription to a single brand of immunoglobulin, regardless of their current IgG therapy.

17 Mar 2011

Blood News and Research

CDC to award $2M grant to continue CARPE program in preventing healthcare-associated infections

Oncologists to discuss treatment of blood cancer in elderly

Researchers identify protein that triggers immune response in TB-infected people

Researchers discover process that regulates DNA maintenance

Experts to present latest information on multiple myeloma at Patient Symposium

JHUSON adds Harvey the Cardiopulmonary Simulator to simulation education

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

UCLA researchers identify new biomarker that can help track amyloid beta in Alzheimer's

Stem cell therapy can reduce heart size, scar tissue and improve function in cardiac patients

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

BUSM scientists identify new biomarker and melanoma treatment target

Stem cell therapy successfully heals a scarred and failing heart

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

FDA grants CSI marketing clearance for Stealth 360° Orbital PAD System

APS ACTION brings experts together to improve patient outcomes

Kentucky Governor signs license bill to practice diabetes education

Major breakthrough in thrombosis

Highmark forces patients with PIDD to switch over to specific IgG therapy

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News